top of page
All Posts
Q2 2023 Product Revenue Analyses
We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see:
Aug 16, 2023


BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
Aug 15, 2023
Q2 2023 Hedge Fund Analysis
SUMMARY
Aug 15, 2023


SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Aug 7, 2023


BIIB & SAGE: Zuranolone
Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...
Aug 7, 2023


Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Jul 31, 2023
Amarin Corporation (AMRN)
Nearing 5 yrs since Reduce- It results
Jul 30, 2023
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH
Jul 30, 2023


How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...
Jul 24, 2023
How to make $$$ investing in biopharma
Consistent with top 36 biopharma hedge funds
Jul 23, 2023
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
